To Top

Content Filter


1495 Articles available
Expanded Capacity

WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services

PR-M04-18-NI-75
Collaboration

Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics

PR-M04-18-NI-64
Oncology

Opdivo (nivolumab), First PD-1 Inhibitor to Demonstrate Superior Survival Benefit Compared with Chemotherapy

PR-M04-18-NI-65
Collaboration

Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford

PR-M04-18-NI-64
Oncology

Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Disease Recurrence or Death by More than 40 Percent

PR-M04-18-NI-63
Expanded Capacity

SeraCare Announces Expansion of Industry's Most Complete and Patient-Like ctDNA Reference Materials

PR-M04-18-NI-61
Immunotherapy

Immunotherapy Prior to Surgery Shows Promise in Fight Against Lung Cancer

PAO-M04-18-NI-016
CAR T

Pfizer and Allogene Therapeutics Form Alliance, Further Developing CAR-T Therapy

PAO-M04-18-NI-015
Innovation

Robotic Microscope Used for Brain Surgery

PAO-M04-18-NI-014
Clinical Trials

Marken Announces Plans To Add Nursing Services To Home-Based Trials

PR-M04-18-NI-69
FDA

New Lung Cancer Treatment Awarded Priority Review by FDA

PAO-M04-18-NI-013
Strategic Partnership

Charles River Laboratories to Expand Partnership with PathoQuest

PAO-M04-18-NI-011
Approval

Fresenius Kabi Announces New Approval and Immediate Availability of Daptomycin for Injection

PR-M04-18-NI-58
Preclinical Data

Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia

PR-M04-18-NI-56
Drug Delivery

Allergan Announces Launch of the TrueTear® Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting

PR-M04-18-NI-55
FDA Guidance

FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests

PR-M04-18-NI-54
Acquisition

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

PR-M04-18-NI-59
Animal Health

LEUKOCARE and Boehringer Ingelheim Enter into a Long-Term Agreement in the Field of Animal Health

PR-M04-18-NI-53
Collaboration

Evotec Forms Collaboration with Petra Pharma on Indigo Platform

PR-M04-18-NI-52
Launch

Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn

PR-M04-18-NI-50
Drug Development

Novartis drug Afinitor DISPERZ® receives FDA approval to treat TSC-associated partial-onset seizures

PR-M04-18-NI-49
Cloud

Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet

PR-M04-18-NI-48
Innovation

Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery

PR-M04-18-NI-47
Next Generation

Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

PR-M04-18-NI-45
Immuno-Oncology

FIMECS, Inc. Concludes Licensing Agreement with Takeda to Develop Novel Immuno-Oncology Therapies

PR-M04-18-NI-44
Oncology

New Breast Cancer Drug Accepted for Review by EMA

PAO-M04-18-NI-010
Clinical Trials

Eli Lilly Gets Good News for Cyramza

PAO-M04-18-NI-009
Acquisition

GSK to Take Over Full Ownership of Consumer Healthcare JV with Novartis

PAO-M04-18-NI-008
Strategic Collaboration

Compugen, MedImmune to Collaborate on Bi- and Multi-Specific Antibodies

PAO-M04-18-NI-007
Strategic Collaboration

Science Exchange and Ranomics Collaborate to Offer Online Access to their VariantFindTM Mutagenesis Platform

PR-M04-18-NI-43
FDA Approval

Rubraca® (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer

PR-M04-18-NI-41
Industry

Casdin Capital to Become Shareholder in BioLife Solutions

PR-M04-18-NI-42
Immuno-oncology

Allogene Therapeutics Completes Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio

PR-M04-18-NI-40
Strategic Partnership

Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership

PR-M04-18-NI-39
Drug Discovery

"Transcriptional wiring" of cancer genes can be resolved using Lexogen's SLAMseq and QuantSeq technologies to facilitate drug discovery

PR-M04-18-NI-38
Acquisition

ImmunoPrecise Acquires ModiQuest Research BV

PR-M04-18-NI-37
Monoclonal antibody

Alopexx Pharmaceuticals' F598 Monoclonal Antibody Binds to poly-N-acetylglucosamine (PNAG) on Microbial Surfaces Offering Potential Protective Immunity Against Multiple Pathogens

PR-M04-18-NI-36
Acquisition

Frontage Acquires Concord Biosciences, Adding Preclinical, Agrochemical and Toxicology Services to the Existing Product Development Portfolio

PR-M04-18-NI-34
Clinical Trials

First Patient Treated in Pivotal Phase 3 Trial to Evaluate OTL38 in the Detection of Ovarian Cancer

PR-M04-18-NI-33
Immuno-Oncology

Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership

PR-M04-18-NI-030
Acquisition

UCB Strengthens Research Capabilities With Acquisition of Element Genomics, a Duke University Biotech Spin-off

PR-M04-18-NI-32
Diagnostics

Pharos Diagnostics Expands Diagnostic Testing Menu to include Routine Testing and Valley Fever (Cocci)

PR-M04-18-NI-025
Acquisition

Terns Pharmaceuticals Acquires Global, Exclusive Rights to Develop and Commercialize Three NASH Assets from Lilly

PR-M04-18-NI-026
Strategic Collaboration

IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets

PR-M04-18-NI-027
Research

Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Initiative

PR-M04-18-NI-028
Strategic Collaboration

Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes

PR-M04-18-NI-029
Collaboration

Kymera Therapeutics Announces Discovery Collaboration with GSK to Advance New Treatment Modality

PR-M04-18-NI-024
Acquisition

Inception Neuroscience Program Acquired by Roche

PR-M04-18-NI-023
CAR T

Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio

PR-M04-18-NI-022
Clinical Trials

SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial

PR-M04-18-NI-020
NDA

Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate

PR-M04-18-NI-019
Acquistion

HGS Acquires AxisPoint Health

PR-M04-18-NI-017
Expanded Capacity

AGC Biologics Increases Footprint in Bothell, WA

PR-M04-18-NI-016
Equipment

Successful Solid Dose Equipment Training

PA0-M04-18-CL-004
Diabetes

Sanofi’s Sotagliflozin Accepted for Review by EMA

PAO-M04-18-NI-006
Approval

Amgen Gets Expanded Approval for Blincyto®

PAO-M04-18-NI-005
Antibiotics

Macrolide Attracts Funding and Executive Talent

PAO-M04-18-NI-004
Licensing

Merck Projected to Spend the Most on Licensing Deals in 2018

PAO-M04-18-NI-003
Results

Positive Results for Pfizer Drug Tafamidis

PAO-M04-18-NI-001
Radio-Conjugates

Companies Join Forces to Develop Novel Radio-Conjugates

PAO-M04-18-NI-002
Next Generation

First Patient Treated on Mevion's Next Generation Proton Therapy System

PR-M04-18-NI-013
Earnings

Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast

PR-M04-18-NI-012
Formulation

Differentiating Generic SODFs with Hard Capsule Formulations

PAO-Q1-18-CL-004
Acquistion

Avara Pharmaceutical Services Finalizes Acquisition of GSK Secondary Manufacturing and Packaging Facility in South Carolina

PR-M04-18-NI-015
Joint Venture

Medicrea Partners with Key Distributor to Form Joint Venture in Belgium

PR-M04-18-NI-010
Innovation

Spinal Resources, Inc.® Announces First Implantation with Swedge™ Pedicle Screw System

PR-M04-18-NI-008
Clinical Trials

Wize Pharma Enrolls First Patient in Phase IV Study of LO2A for Symptomatic Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome

PR-M04-18-NI-005
Innovation

VICAM Introduces a New Method for BPA Detection

PR-M04-18-NI-004
Clinical Trials

Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine

PR-M04-18-NI-001
Expanded Capacity

Abzena’s New GMP Manufacturing Suite Expands ADC Chemistry Solutions at Bristol Site

PR-M03-18-NI-105
Drug Development

Partnership to Develop Clostridial-Based Medicines Moves Forward

PR-M03-18-NI-104
Acquistion

FUJIFILM Expands into Bio-Medical Business with Acquisition

PR-M03-18-NI-103
Acquistion

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

PR-M03-18-NI-106
HIV

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

PR-M03-18-NI-111
Oncology

Outcome Health And The Colorectal Cancer Alliance Announce Campaign To Support Patient Education

PR-M03-18-NI-109
Cell and Gene Therapy

New Stem Cell Therapy Approved in Europe

PR-M03-18-NI-102
Clinical Data

Clinical Study Data for New MS Drug Looks Promising

PR-M03-18-NI-101
Probiotics

J&J Involved in Probiotics Development Program

PR-M03-18-NI-100
Operational Excellence

Transforming A CDMO Using an Operational Excellence Approach

PAO-M03-18-CL-003
Clinical Trials

BrainStorm Cell Therapeutics' Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients

PR-M03-18-NI-108
Awareness

Boehringer Ingelheim and Minor League Baseball Team Up to Raise Awareness of Rare Lung Disease – IPF

PR-M03-18-NI-106
Oncology

Biovica International AB: New Positive Results Support Early Treatment Evaluation of Breast Cancer Using DiviTum

PR-M03-18-NI-105
Conversion

Evotec AG plans conversion into European Company (SE)

PR-M03-18-NI-103
Acquistion

BioIVT Acquires Ascendance Biotechnology, Expanding its Drug Safety Testing and Toxicology Portfolios 

PR-M03-18-NI-102
Clinical Data

New Study finds younger aged children with symptoms of ADHD have reduced brain size

PR-M03-18-NI-101
FDA

FDA approves Toujeo® Max SoloStar®

PR-M03-18-NI-101
Award

Piramal Pharma Solutions Wins in Six Categories at the 'CMO Leadership Awards 2018'

PR-M03-18-NI-099
Generic

Teva Announces the Launch of a Generic Version of Lialda® in the United States

PR-M03-18-NI-100
Clinical Trials

Clinical Trial Access to Expand Following Receipt of Additional Funding    

PAO-M03-18-NI-026
Acquisition

Citoxlab Acquires Solvo Biotechnology    

PAO-M03-18-NI-025
Ultrasound

Samsung Unveils New Innovative Ultrasound System at AIUM 2018

PR-M03-18-NI-097
Clinical Data

Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS

PR-M03-18-NI-095
FDA

Novartis drug Tasigna® approved by FDA to treat children with rare form of leukemia

PR-M03-18-NI-094
Clinical Trials

Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX®  (varenicline) in Adolescent Smokers

PR-M03-18-NI-093
Blockbuster

Pace of Pharmaceutical Innovation Accelerates as Record Number of New Blockbuster Drugs Forecast to Hit the Market in 2018

PR-M03-18-NI-092
Discovery

New ALS Gene Discovered: KIF5A

PR-M03-18-NI-091
Partnership

Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies

PR-M03-18-NI-090
Clinical Trials

AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T)

PR-M03-18-NI-088
Drug Development

More Good News for Novo Nordisk’s Semaglutide and Weight Loss

PAO-M03-18-NI-024
Oncology

Adaptimmune’s GSK-Partnered T cells Trigger Responses in Solid Tumor Patients

PAO-M03-18-NI-023
Production

LANXESS Starts Production Line for Specialty Compounds in Germany

PAO-M03-18-NI-022
Influenza

Anti-Flu Drug Exploits Weakness in H3N2 Strain

PAO-M03-18-NI-021
Oncology

Tumor Derived T cells Demonstrate Potential Against Ovarian Cancer

PAO-M03-18-NI-020
Acquistion

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification

PR-M03-18-NI-087
Clinical Trial Data

Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed in large prospective real-world analysis

PR-M03-18-NI-086
Clinical Trials

Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System

PR-M03-18-NI-083
Immunotherapy

Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis

PR-M03-18-NI-082
Cannibis

Medical Marijuana Moves to the Big Time

PAO-M03-18-NI-019
Vaccine

Shingrix Vaccine Available at CVS

PAO-M03-18-NI-018
Expanded Capacity

Hovione Reports on Recent Capacity Expansion and Future Plans to Support Growth

PR-M03-18-NI-081
Appointment

Brammer Bio Expands Leadership Team for Commercial Readiness

PR-M03-18-NI-080
Capacity Expansion

Sartorius Stedim Biotech Supports ABL Europe in Successful Completion of Viral Vector GMP Capacity Expansion

PR-M03-18-NI-079
Appointment

AMPAC Fine Chemicals Announces New Addition To Their Executive Team

PR-M03-18-NI-078